How many institutions held SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q4 2016?

40 institutional investors reported SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q4 2016. Use the holders table for investor-level position and value details.

Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)

Q: What does CUSIP 87184Q107 represent in this 13F holders report?

CUSIP 87184Q107 is the security identifier for SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 87184Q107

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 27,995,500
Total 13F shares: 12,922,246
Share change: +161,444
Total reported value: $157,133,459
Price per share: $12.16
Number of holders: 40
Value change: +$1,761,438
Number of buys: 22
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 87184Q107:

Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Flagship Pioneering, LLC	13F	Company	17%	4,806,656	$66,668,000	—	30 Sep 2016	13F
FMR LLC	13F	Company	13%	3,506,155	$48,631,000	—	30 Sep 2016	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	6.5%	1,812,778	$25,143,000	—	30 Sep 2016	13F
Redmile Group, LLC	13F	Company	3.2%	892,782	$11,736,000	—	30 Sep 2016	13F
Aisling Capital LLC	13F	Company	1.8%	508,565	$7,054,000	—	30 Sep 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	0.73%	204,465	$2,836,000	—	30 Sep 2016	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.54%	150,000	$2,081,000	—	30 Sep 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.49%	136,407	$1,892,000	—	30 Sep 2016	13F
BlackRock Fund Advisors	13F	Company	0.45%	124,634	$1,729,000	—	30 Sep 2016	13F
Alyeska Investment Group, L.P.	13F	Company	0.4%	112,637	$1,562,000	—	30 Sep 2016	13F
EcoR1 Capital, LLC	13F	Company	0.23%	63,596	$882,000	—	30 Sep 2016	13F
Foresite Capital Management III, LLC	13F	Company	0.21%	60,000	$832,000	—	30 Sep 2016	13F
Casdin Capital, LLC	13F	Company	0.18%	50,000	$694,000	—	30 Sep 2016	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.18%	49,000	$680,000	—	30 Sep 2016	13F
AWM Investment Company, Inc.	13F	Company	0.17%	47,550	$660,000	—	30 Sep 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	34,750	$481,000	—	30 Sep 2016	13F
MORGAN STANLEY	13F	Company	0.12%	33,814	$469,000	—	30 Sep 2016	13F
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS	13F	Company	0.11%	30,770	$427,000	—	30 Sep 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	29,457	$409,000	—	30 Sep 2016	13F
STATE STREET CORP	13F	Company	0.09%	24,979	$347,000	—	30 Sep 2016	13F
VANGUARD GROUP INC	13F	Company	0.06%	15,427	$214,000	—	30 Sep 2016	13F
HAMILTON LANE ADVISORS LLC	13F	Company	0.05%	13,880	$193,000	—	30 Sep 2016	13F
Spark Investment Management LLC	13F	Company	0.04%	11,600	$160,000	—	30 Sep 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	9,900	$137,000	—	30 Sep 2016	13F
GLENMEDE TRUST CO NA	13F	Company	0.03%	9,324	$129,000	—	30 Sep 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.02%	6,457	$90,000	—	30 Sep 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.02%	4,933	$68,000	—	30 Sep 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.01%	2,443	$34,000	—	30 Sep 2016	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	1,542	$21,000	—	30 Sep 2016	13F
STRS OHIO	13F	Company	0.01%	1,500	$20,000	—	30 Sep 2016	13F
CITIGROUP INC	13F	Company	0%	381	$5,000	—	30 Sep 2016	13F
BARCLAYS PLC	13F	Company	0%	371	$5,000	—	30 Sep 2016	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	166	$2,302	—	30 Sep 2016	13F
Creative Planning	13F	Company	0%	175	$2,000	—	30 Sep 2016	13F
ROYAL BANK OF CANADA	13F	Company	0%	100	$1,000	—	30 Sep 2016	13F

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q4 2016

As of 31 Dec 2016, Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,922,246 shares. The largest 10 holders included Flagship Pioneering Inc., FMR LLC, DEERFIELD MANAGEMENT CO, Redmile Group, LLC, Aisling Capital LLC, BAKER BROS. ADVISORS LP, Casdin Capital, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Fund Advisors, and JPMORGAN CHASE & CO. This page lists 40 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders

Q4 2016 holders

Holder diff

Investor	Q3 2016 Shares	Q4 2016 Shares	Share Diff	Share Chg %	Q3 2016 Value $	Q4 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.